Dhipatimendi rePasi Pose

CT011 chigadzirwa cheGPC3 CAR T-cell chinoda kurapwa kwehepatocellular carcinoma (HCC). CT011 yakapihwa mvumo yeIND kubva kuNMPA muna 2019 yekurapa varwere vane GPC3-positive solid bundu, iro raive mvumo yekutanga yeIND yekurapa CAR T-cell kubva ku ...Verenga zvakawanda»

Purofesa weyunivhesiti yekuRussia ane makore ekuma170 ari kurwara nechirwere che multiple myeloma. Mushure mekurapwa kakawanda uye kuisirwa autologous kaviri, akadzidza nezvekurapa kweCAR-T kuChina kunoshanda zvakanyanya mukurwisa kenza, saka akauya kuChina kuzogamuchira CAR-T cell...Verenga zvakawanda»

Musi wa20 Chikunguru, New Drug Application (NDA) yepCAR-19B yakagadzirwa yega nePrecision Biology yakagamuchirwa zviri pamutemo neChina National Medical Products Administration (NMPA). Ichi chigadzirwa ndicho chekutanga cheCAR-T chechirwere cheleukemia chevana muChina, chinoshandiswa kurapa varwere vane makore 3-21 ...Verenga zvakawanda»

Satricabtagene autoleucel (Satri-cel, CT041) chigadzirwa cheCAR T-cell chinorwisa puroteni inonzi Claudin18.2 iyo inogona kuva yepamusoro-soro pasi rose. Satri-cel inodzivirira Claudin18.2 solid bundu, ichinyanya kutarisa kenza yemudumbu/gastroesophageal junction canc...Verenga zvakawanda»

Musi wa6 Gunyana, 2021, JW Therapeutics yakazivisa kuti National Medical Products Administration (NMPA) yeChina yabvumidza New Drug Application (NDA) ye anti-CD19 autologous chimeric antigen receptor T (CAR-T) cell immunotherapy product relmacabtagene autoleucel injection (relma-cel) ...Verenga zvakawanda»

Equecabtagene autoleucel (eque-cel), iyo inotorwa nevanhu zvizere seB-cell maturation antigen-targeting chimeric antigen receptor (CAR) T-cell therapy, yakaratidza mukana wekurapa recurly kana refractory multiple myeloma (R/RMM). Musi wa30 Chikumi 2023, China's National Medical Products Admi...Verenga zvakawanda»

Musi wa11 Gumiguru, 2024, National Medical Product Administration (NMPA) yeChina yakabvumidza chikumbiro cheInvestigational New Drug (IND) cheInaticabtagene Autoleucel (CNCT19 Injection), iyo CD19-targetted autologous chimeric antigen receptor (CAR)-T cell therapy, kurapa Immune thrombocytopenia ...Verenga zvakawanda»

Musi wa1 Kurume, 2024, China National Medical Products Administration (NMPA) yakabvumidza kuburitswa kwechigadzirwa cheCAR-T cell Zevorcabtagene AutoLeucel (Zevor-cel, CT053) chekurapa varwere vakuru vane myeloma yakadzoka kana kuti isingadzoreki iyo yakanga yafambira mberi mushure mekurapwa kanenge katatu (...Verenga zvakawanda»